Russell Investments Group, Ltd. Fibrogen Inc Transaction History

Russell Investments Group, Ltd.

  • $66.8 Billion
  • Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Fibrogen Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 70,891 shares of FGEN stock, worth $34,027. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70,891
Previous 68,681 3.22%
Holding current value
$34,027
Previous $61,000 54.1%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$0.33 - $1.26 $729 - $2,784
2,210 Added 3.22%
70,891 $28,000
Q2 2024

Aug 08, 2024
BUY
$0.89 - $2.36 $4,471 - $11,856
5,024 Added 7.89%
68,681 $61,000
Q1 2024

May 08, 2024
BUY
$0.73 - $2.73 $348 - $1,302
477 Added 0.75%
63,657 $149,000
Q4 2023

Feb 05, 2024
SELL
$0.38 - $0.91 $1,451 - $3,475
-3,819 Reduced 5.7%
63,180 $56,000
Q3 2023

Nov 13, 2023
SELL
$0.79 - $2.83 $57,256 - $205,107
-72,476 Reduced 51.96%
66,999 $57,000
Q2 2023

Aug 10, 2023
BUY
$2.49 - $20.59 $1,957 - $16,183
786 Added 0.57%
139,475 $376,000
Q1 2023

May 09, 2023
SELL
$15.95 - $25.18 $822,780 - $1.3 Million
-51,585 Reduced 27.11%
138,689 $2.59 Million
Q4 2022

Feb 08, 2023
BUY
$13.27 - $17.73 $1.11 Million - $1.49 Million
83,821 Added 78.74%
190,274 $3.05 Million
Q3 2022

Nov 04, 2022
SELL
$11.4 - $14.6 $121,831 - $156,030
-10,687 Reduced 9.12%
106,453 $1.38 Million
Q2 2022

Jul 29, 2022
SELL
$7.94 - $12.96 $85,942 - $140,279
-10,824 Reduced 8.46%
117,140 $1.24 Million
Q1 2022

May 05, 2022
SELL
$12.02 - $16.79 $221,468 - $309,355
-18,425 Reduced 12.59%
127,964 $1.54 Million
Q4 2021

Jan 21, 2022
SELL
$9.93 - $15.39 $305,198 - $473,011
-30,735 Reduced 17.35%
146,389 $2.06 Million
Q3 2021

Nov 08, 2021
SELL
$10.18 - $26.64 $507,707 - $1.33 Million
-49,873 Reduced 21.97%
177,124 $1.81 Million
Q2 2021

Aug 04, 2021
BUY
$18.57 - $35.68 $2.91 Million - $5.58 Million
156,490 Added 221.95%
226,997 $6.05 Million
Q1 2021

May 10, 2021
SELL
$31.0 - $55.72 $1.8 Million - $3.23 Million
-58,011 Reduced 45.14%
70,507 $2.39 Million
Q4 2020

Feb 08, 2021
SELL
$37.09 - $48.97 $962,522 - $1.27 Million
-25,951 Reduced 16.8%
128,518 $4.77 Million
Q3 2020

Nov 09, 2020
BUY
$40.47 - $45.5 $3.92 Million - $4.41 Million
96,960 Added 168.6%
154,469 $6.35 Million
Q2 2020

Aug 05, 2020
BUY
$32.57 - $42.83 $16,610 - $21,843
510 Added 0.89%
57,509 $2.33 Million
Q1 2020

May 06, 2020
BUY
$23.3 - $45.96 $19,362 - $38,192
831 Added 1.48%
56,999 $1.98 Million
Q4 2019

Jan 29, 2020
BUY
$34.58 - $48.06 $273,043 - $379,481
7,896 Added 16.36%
56,168 $2.41 Million
Q3 2019

Nov 01, 2019
BUY
$36.98 - $48.45 $42,600 - $55,814
1,152 Added 2.44%
48,272 $1.79 Million
Q1 2019

May 13, 2019
SELL
$42.83 - $59.91 $60,861 - $85,132
-1,421 Reduced 2.93%
47,120 $2.56 Million
Q4 2018

Feb 11, 2019
BUY
$37.97 - $60.16 $659,614 - $1.05 Million
17,372 Added 55.73%
48,541 $2.25 Million
Q3 2018

Oct 26, 2018
BUY
$56.3 - $67.25 $1.37 Million - $1.64 Million
24,393 Added 359.99%
31,169 $1.89 Million
Q2 2018

Aug 08, 2018
SELL
$44.9 - $64.95 $91,326 - $132,108
-2,034 Reduced 23.09%
6,776 $423,000
Q1 2018

May 11, 2018
BUY
$45.35 - $61.65 $186,751 - $253,874
4,118 Added 87.77%
8,810 $407,000
Q4 2017

Feb 06, 2018
SELL
$41.95 - $60.1 $448,445 - $642,469
-10,690 Reduced 69.5%
4,692 $229,000
Q3 2017

Nov 07, 2017
BUY
$33.4 - $53.9 $513,758 - $829,089
15,382
15,382 $827,000

Others Institutions Holding FGEN

# of Institutions
82
Shares Held
47.1M
Call Options Held
387K
Put Options Held
672K
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $45M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email